Home

Blândeţe sindromul mentalitatea number of exacerbations per year Cadă inerţie câteva

Mean number of exacerbations in the first year of follow-up, by BTS... |  Download Scientific Diagram
Mean number of exacerbations in the first year of follow-up, by BTS... | Download Scientific Diagram

Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE  revisited | European Respiratory Society
Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited | European Respiratory Society

S111 Human rhinovirus infection and exacerbation frequency at COPD  exacerbation | Thorax
S111 Human rhinovirus infection and exacerbation frequency at COPD exacerbation | Thorax

COPD exacerbations: definitions and classifications | European Respiratory  Society
COPD exacerbations: definitions and classifications | European Respiratory Society

Factors associated with change in exacerbation frequency in COPD |  Respiratory Research | Full Text
Factors associated with change in exacerbation frequency in COPD | Respiratory Research | Full Text

Impact of exacerbations on COPD | European Respiratory Society
Impact of exacerbations on COPD | European Respiratory Society

SGRQ Predicts Outcomes in COPD | Journal of COPD Foundation
SGRQ Predicts Outcomes in COPD | Journal of COPD Foundation

Effect of Tiotropium on Exacerbations | Journal of COPD Foundation
Effect of Tiotropium on Exacerbations | Journal of COPD Foundation

JCM | Free Full-Text | Chronic Bronchitis Affects Outcomes in Smokers  without Chronic Obstructive Pulmonary Disease (COPD) | HTML
JCM | Free Full-Text | Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD) | HTML

Exacerbation history, severity of dyspnoea and maintenance treatment  predicts risk of future exacerbations in patients with COPD in the general  population - Respiratory Medicine
Exacerbation history, severity of dyspnoea and maintenance treatment predicts risk of future exacerbations in patients with COPD in the general population - Respiratory Medicine

Number of exacerbation days per year for patients in the intervention... |  Download Scientific Diagram
Number of exacerbation days per year for patients in the intervention... | Download Scientific Diagram

Total number of exacerbations per year in each class of exacerbation... |  Download Scientific Diagram
Total number of exacerbations per year in each class of exacerbation... | Download Scientific Diagram

Article medicale Tunisie, Article medicale COPD, exacerbation, phenotype,  prognosis
Article medicale Tunisie, Article medicale COPD, exacerbation, phenotype, prognosis

Should the number of acute exacerbations in the previous year be used to  guide treatments in COPD? | European Respiratory Society
Should the number of acute exacerbations in the previous year be used to guide treatments in COPD? | European Respiratory Society

COPD Exacerbation Costs in the IMPACT Study: A Within-Trial Analysis
COPD Exacerbation Costs in the IMPACT Study: A Within-Trial Analysis

annual rates of exacerbations at follow-up (per person-year).... | Download  Scientific Diagram
annual rates of exacerbations at follow-up (per person-year).... | Download Scientific Diagram

Total number of exacerbations per year in each class of exacerbation... |  Download Scientific Diagram
Total number of exacerbations per year in each class of exacerbation... | Download Scientific Diagram

Exacerbation-free time' to assess the impact of exacerbations in patients  with chronic obstructive pulmonary disease (COPD): a prospective  observational study | npj Primary Care Respiratory Medicine
Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study | npj Primary Care Respiratory Medicine

Seasonality and determinants of moderate and severe COPD exacerbations in  the TORCH study | European Respiratory Society
Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study | European Respiratory Society

A Retrospective Longitudinal Within-Subject Risk Interval Analysis of  Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic  Obstructive Pulmonary Disease | PLOS ONE
A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease | PLOS ONE

Frequency of acute exacerbations per year in patients with COPD and in... |  Download Scientific Diagram
Frequency of acute exacerbations per year in patients with COPD and in... | Download Scientific Diagram

Mean annual total and severe exacerbation rates during follow-up.... |  Download High-Resolution Scientific Diagram
Mean annual total and severe exacerbation rates during follow-up.... | Download High-Resolution Scientific Diagram

Respondents' responses concerning the number of exacerbations per year... |  Download Scientific Diagram
Respondents' responses concerning the number of exacerbations per year... | Download Scientific Diagram

Telomere length in COPD: Relationships with physical activity, exercise  capacity, and acute exacerbations | PLOS ONE
Telomere length in COPD: Relationships with physical activity, exercise capacity, and acute exacerbations | PLOS ONE

Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE  revisited | European Respiratory Society
Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited | European Respiratory Society

Effects of Tiotropium on Exacerbations in Patients with COPD with Low or  High Risk of Exacerbations: A Post-Hoc Analysis from the 4-Year UPLIFT®  Trial. - Abstract - Europe PMC
Effects of Tiotropium on Exacerbations in Patients with COPD with Low or High Risk of Exacerbations: A Post-Hoc Analysis from the 4-Year UPLIFT® Trial. - Abstract - Europe PMC

Acute Exacerbations of COPD: Avoiding Danger and Death | Consultant360
Acute Exacerbations of COPD: Avoiding Danger and Death | Consultant360